Alvogen Thyro-Tabs levothyroxine 150mcg recalled for wrong strength tablets in bottle
One bottle of Alvogen Thyro-Tabs 150mcg levothyroxine tablets (Lot MHA21825) was found to contain 88mcg tablets instead of the labeled 150mcg strength. This mix-up affects only a single bottle distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have Lot MHA21825 (expires December 31, 2027) of Alvogen Thyro-Tabs 150mcg
- Contact your pharmacy or doctor if you have this lot—do not stop taking your medication without guidance
- Your pharmacist can verify the tablet strength and provide correct medication if needed
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Illnesses reported
- None reported
- Manufactured in
- 44 Whippany Rd Ste 300, Morristown, NJ, United States
- Classification
- Class II
- Recall number
- D-0259-2026
In the FDA's words
- Description
- Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10. Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. Lot # MHA21825, Exp Date: December 31, 2027 Distribution: US Nationwide.
- Hazard
- Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.